Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML

被引：0
|
作者：
Kang, Dongwoo [1 ]
Passarell, Julie [2 ]
Abutarif, Malaz A. [1 ]
Mendell, Jeanne [1 ]
Yin, Ophelia [1 ]
机构：
[1] Daiichi Sankyo Inc, Basking Ridge, NJ USA
[2] Cognigen Corp, Buffalo, NY USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-122582
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Azacitidine for the treatment of relapsed and refractory AML in older patients
    Itzykson, Raphael
    Thepot, Sylvain
    Berthon, Celine
    Delaunay, Jacques
    Bouscary, Didier
    Cluzeau, Thomas
    Turlure, Pascal
    Prebet, Thomas
    Dartigeas, Caroline
    Marolleau, Jean-Pierre
    Recher, Christian
    Plantier, Isabelle
    Stamatoullas, Aspasia
    Devidas, Alain
    Taksin, Anne-Laure
    Guieze, Romain
    Caillot, Denis
    Vey, Norbert
    Ades, Lionel
    Ifrah, Norbert
    Dombret, Herve
    Fenaux, Pierre
    Gardin, Claude
    LEUKEMIA RESEARCH, 2015, 39 (02) : 124 - 130
  • [42] Population Pharmacokinetics, Efficacy Exposure-Response Analysis
    Chan, Phyllis
    Yu, Jiajie
    Chinn, Leslie
    Prohn, Marita
    Huisman, Jan
    Matzuka, Brett
    Hanley, William
    Tuckwell, Katie
    Quartino, Angelica
    PHARMACEUTICAL RESEARCH, 2020, 37 (02)
  • [43] Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
    Kang, Dongwoo
    Ludwig, Elizabeth
    Jaworowicz, David
    Huang, Hannah
    Fiedler-Kelly, Jill
    Cortes, Jorge
    Ganguly, Siddhartha
    Khaled, Samer
    Kraemer, Alwin
    Levis, Mark
    Martinelli, Giovanni
    Perl, Alexander
    Russell, Nigel
    Abutarif, Malaz
    Choi, Youngsook
    Yin, Ophelia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (04) : 513 - 523
  • [44] Cabozantinib exposure-response analyses of efficacy and safety in patients with advanced hepatocellular carcinoma
    Linh Nguyen
    Chapel, Sunny
    Tran, Benjamin Duy
    Lacy, Steven
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2019, 46 (06) : 577 - 589
  • [45] Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures
    Miller, R
    Frame, B
    Corrigan, B
    Burger, P
    Bockbrader, H
    Garofalo, E
    Lalonde, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) : 491 - 505
  • [46] Exposure-Response Analyses Indicate a Promising Benefit/Risk Profile of Mosunetuzumab in Relapsed and Refractory Non-Hodgkin Lymphoma
    Li, Chi-Chung
    Bender, Brendan
    Yin, Shen
    Li, Zao
    Zhang, Cindy
    Hernandez, Genevive
    Kwan, Antonia
    Sun, Laura
    Adamkewicz, Joanne I.
    Wang, Hong
    Dimier, Natalie
    Lim, Sue-Zen
    O'Hear, Carol
    Sehn, Laurie H.
    Flinn, Ian W.
    Yoon, Sung-Soo
    Budde, Lihua E.
    Li, Chunze
    Wei, Michael C.
    BLOOD, 2019, 134
  • [47] Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid Leukemia
    Kang, Dongwoo
    Ludwig, Elizabeth
    Jaworowicz, David
    Huang, Hannah
    Fiedler-Kelly, Jill
    Cortes, Jorge
    Ganguly, Siddhartha
    Khaled, Samer
    Kraemer, Alwin
    Levis, Mark
    Martinelli, Giovanni
    Perl, Alexander
    Russell, Nigel
    Abutarif, Malaz
    Choi, Youngsook
    Mendell, Jeanne
    Yin, Ophelia
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (12): : 1629 - 1641
  • [48] HIGH RESPONSE RATE AND BRIDGING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH QUIZARTINIB (AC220) IN PATIENTS WITH FLT3-ITD-POSITIVE RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
    Levis, M.
    Cortes, J.
    Perl, A.
    Doehner, H.
    Steffens, B.
    Rousselot, P.
    Martinelli, G.
    Estey, E.
    Burnett, A.
    Gammon, G.
    Trone, D.
    Dombret, H.
    HAEMATOLOGICA, 2013, 98 : 17 - 17
  • [49] Real-World Safety and Efficacy of Gemtuzumab Ozogamicin in Relapsed or Refractory AML
    Bouligny, Ian M.
    Murray, Graeme
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Maher, Keri
    BLOOD, 2022, 140 : 11744 - 11744
  • [50] Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections
    Passarell, J. A.
    Meagher, A. K.
    Liolios, K.
    Cirincione, B. B.
    Van Wart, S. A.
    Babinchak, T.
    Ellis-Grosse, E. J.
    Ambrose, P. G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) : 204 - 210
12345